Noom Launches At-Home Blood Test Kit for Metabolic Health Tracking
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 27, 2026 | Cardiovascular, Company News, Diabetes & Metabolic Diseases |
The new kit uses Tasso+ collection technology and certified laboratory analysis to monitor 17 health markers, including blood sugar and lipid levels.
Read MorePosted by CLP Edit Staff | May 26, 2026 | Cancer, Company News, Digital Pathology |
The $750 million deal aims to integrate AI-powered technology and image management systems into pathology laboratory workflows.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Company News, Digital Pathology, Prostate |
Tempus has launched the ArteraAI Prostate Test, a CLIA-certified, CAP-accredited AI tool for metastatic hormone-sensitive prostate cancer, offering personalized risk estimates and designed to support treatment decisions, according to the company.
Read MorePosted by CLP Edit Staff | May 22, 2026 | Cancer, Company News, Molecular Diagnostics |
The FDA has approved Guardant360 Liquid CDx, a blood-based test that integrates genomic and epigenomic profiling for advanced cancer, offering a broader genomic footprint and faster results.
Read MorePosted by CLP Edit Staff | May 21, 2026 | Cancer, Company News, Molecular Diagnostics |
TGen has launched JAYseq, a clinical whole genome sequencing test for multiple myeloma that delivers results in 72 hours, enabling rapid identification of genetic changes and immunotherapy targets, according to the institute.
Read More